INTRODUCTION
Tissue factor (TF) is a 47-kDa transmembrane glycoprotein that initiates the coagulation protease cascades [1] . Bacterial lipopolysaccharide (LPS) induces the transient expression of TF in human monocytes and monocytic cells, which is mediated at the transcriptional level by the transcription factors activated protein-1 (AP-1), nuclear factor (NF)-B, and Egr-1 and at the post-transcriptional level, by a transient stabilization of TF mRNA [2] [3] [4] [5] . Aberrant TF expression contributes to thrombosis in patients with atherosclerosis, cancer, and sepsis [6, 7] .
Glucocorticoids are widely used as anti-inflammatory drugs to treat various inflammatory diseases [8, 9] . These drugs suppress the expression of proinflammatory mediators, such as cytokines, chemokines, inducible nitric oxide synthase (iNOS), and adhesion molecules [8, 10] . The glucocorticoid dexamethasone (Dex) has been shown to inhibit LPS induction of inflammatory genes in monocytic cells, such as tumor necrosis factor ␣ (TNF-␣), by blocking the activation of the transcription factors NF-B and AP-1 [11, 12] . Dex also inhibits the expression of inflammatory mediators by decreasing the stability of interleukin (IL)-1␤, iNOS, cyclooxygenase-2, and monocyte chemoattractant protein-1 (MCP-1) mRNAs [13] [14] [15] [16] [17] . In contrast, Dex enhances LPS induction of TF expression in human monocytes and monocytic THP-1 cells [18] . Similarly, leukocytes isolated from rabbits presensitized with glucocorticoids before injection with LPS expressed higher levels of procoagulant activity than leukocytes from rabbits given LPS alone [19, 20] . However, unlike monocytic cells, Dex did not enhance LPS induction of TF expression in endothelial cells [18] .
The transient expression of TF and inflammatory mediators in monocytic cells is controlled, in part, by the rapid turnover of their mRNAs. AU-rich elements (AREs) present in the 3Ј-untranslated region (UTR) of these mRNAs bind various proteins that increase or decrease their stability [21] [22] [23] [24] [25] . A common regulatory element within AREs is the pentamer AUUUA [22, 26] . The human TF mRNA contains several AREs in the 3Ј-UTR, which include AUUUA pentamers, poly U tracts, and a UUAUUUAAU nanomer [27] . These AREs in the human TF mRNA are functional, as the last 600 nucleotides (nt) of TF 3Ј-UTR conferred instability to a ␤-globin transcript [28] . Indeed, TF mRNA has been assigned to the group III cluster (WAUUU AUUUA UUUAW) of the AREmRNA database (ARED) [29] .
In this study, we examined the mechanism by which Dex enhances LPS induction of TF expression in human monocytic THP-1 cells. We found that Dex enhanced LPS induction of TF activity and TF mRNA expression by increasing the stability of TF mRNA.
MATERIALS AND METHODS

Cell culture
THP-1 monocytic cells were obtained from American Type Culture Collection (Manassas, VA) and were cultured in RPMI 1640 (Gibco-BRL Life Technologies, Gaithersburg, MD) with 8% fetal calf serum (Omega Scientific, Tarzana, CA), 2 mM L-glutamine (Irvine Scientific, Santa Ana, CA), 10 mM HEPES (Gibco-BRL Life Technologies), and 2-mercaptoethanol (50 M). Cells were stimulated with vehicle (dimethyl sulfoxide), Dex alone (0.01-1 M; Sigma Chemical Co., St. Louis, MO), and LPS alone (1 g/ml; Escherichia coli 0111:B4, Calbiochem, San Diego, CA) or were preincubated for 30 min with Dex before LPS stimulation.
Measurement of TF, TNF-␣, and MCP-1 expression
Levels of TNF-␣ and MCP-1 in the cell-culture supernatant were measured using commercial enzyme-linked immunosorbent assay (ELISA) kits (R&D Systems, Minneapolis, MN). For TF activity, cell pellets were solubilized at 37°C for 15 min in n-octyl-␤-D-glucopyranoside (15 mM; Calbiochem). TF activity was assayed using a one-stage clotting with human plasma [30] . Clotting times were converted to TF activity by comparison with a standard curve established with affinity-purified TF from human brain tissue [30] .
Northern blotting
Total cellular RNA was extracted using Trizol (Gibco-BRL Life Technologies), and Northern blotting was performed [3] . A 641-base pair (bp) human TF cDNA fragment, an 800-bp human TNF-␣ cDNA fragment, and a 550-bp human MCP-1 cDNA fragment were labeled with [␣ 32 P] deoxycytidine triphosphate (dCTP; ICN Biomedicals, Costa Mesa, CA) using a Prime-It-Kit TM (Stratagene Cloning Systems, San Diego, CA) and were used as probes. The housekeeping gene, glyceraldehyde 3-phosphate dehydrogenase (G3PDH; Clontech Laboratories, Palo Alto, CA), served as a loading control. Bands were visualized by autoradiography.
Plasmids and transfections
Porcine TF (pTF)-luciferase (LUC) contains -2106 bp of the human TF promoter [4] , pTNF-␣-LUC contains -615 bp of the human TNF-␣ promoter [31] , pMCP-1-LUC contains -515 bp of the human MCP-1 promoter [32] , and p(B) 4 LUC contains four copies of a NF-B site [33] . These promoters were cloned upstream of the firefly LUC reporter gene in pGL2-basic (Promega, Madison, WI). Transfections were performed using diethylaminoethyl dextran [4] . After transfection, cells were incubated in complete media for 46 h at 37°C before LPS stimulation for 5 h. Firefly LUC activity was measured in cell lysates, as described in the manufacturer's protocol (Promega) using a Monolight 2010 luminometer (Analytical Luminescence Laboratory, San Diego, CA). Cells were cotransfected with Renilla LUC-thymidine kinase (RL-TK; Promega), which expresses RL (Promega) to normalize the firefly LUC activity.
Nuclear run-on experiments
Nuclear run-on experiments were performed as described [3] . For run-on reactions, nuclei were mixed with an equal volume of the reaction buffer [10 mM Tris-HCl (pH 8.0), 5 mM MgCl 2 , 0.3 M KCl, 1 mM each adenosine 5Ј-triphosphate (ATP), CTP, and guanosine 5Ј-triphosphate, 5 mM dithiothreitol (DTT), 25 U RNasin (Promega) per ml, 10 mM creatine phosphate, 20 U creatine phosphokinase per ml, 0.1 mM phenylmethylsulfonyl fluoride (PMSF)] containing 100 Ci [␣-
32 P] uridine 5Ј-triphosphate (UTP; 3000 Ci/mmol, Amersham, Little Chalfont, UK) and incubated for 30 min at 30°C. Radiolabeled RNA was hybridized with a 3705-bp EcoRI-PstI genomic TF fragment (nt -377-ϩ3328 [34] ) and a G3PDH gene fragment.
Measurement of the stability of TF, TNF-␣, and MCP-1 mRNAs in THP-1 cells
The effect of Dex on the stability of TF, TNF-␣, and MCP-1 mRNAs was evaluated using the transcriptional inhibitor, actinomycin D (10 g/ml; Gibco-BRL Life Technologies), as described [3] . Actinomycin D was added 30 min after LPS stimulation with or without Dex. Cells were harvested at various time-points (0 -3 h) following actinomycin D treatment, and RNA was isolated. Northern blotting was performed to determine the levels of TF, TNF-␣, and MCP-1 mRNAs. G3PDH was used to monitor loading.
Preparation of protein extracts
Cytoplasmic extracts were prepared as described [35] from unstimulated THP-1 cells or cells treated with Dex alone (90 min), LPS alone (60 min), or 30 min preincubation with Dex before LPS stimulation for 60 min. Cells were harvested and washed with phosphate-buffered saline followed by ice-cold EBKL buffer (25 mM HEPES, pH 7.6, mM MgCl 2 , 1.5 mM KCl, 0.1% Nonidet P-40, 2 mM DTT) containing protease inhibitors (1 mM PMSF) and complete protease inhibitors (Boehringer Mannheim, Lewes, UK). Cells were resuspended in 1 ml EBKL buffer and lysed with 25 strokes in a dounce homogenizer. The nuclei were pelleted by centrifugation at 12,000 g for 15 min, and the supernatant containing the cytoplasmic proteins was stored at -80°C.
In vitro transcription
Polymerase chain reaction (PCR) generated a DNA fragment containing the final 297-bp of the 3Ј-UTR region (ϩ1855-ϩ2152 bp) [27] of the human TF mRNA using sense (5Ј CGGGATCCCGGTGCAGGAGACATTGGTATT 3Ј) and antisense (5Ј CCGCTCGAGCGGAACAATTCCCAGTCACCTTT 3Ј) primers. Underlined sequences indicate the cloning sites. The PCR fragment was subcloned into the BamHI and XhoI sites of pBluescript KSϩ (Stratagene Cloning Systems). A synthetic 60-bp poly A tail was ligated at the 3Ј end of the 297-bp fragment. The plasmid was linearized with KpnI and used as a template for the generation of a 357-nt (297ntϩ60 nt) RNA transcript using T7 RNA polymerase (Riboprobe system, Promega). A control 210-nt transcript was generated by adding a synthetic 60-bp poly A tail to the end of the polylinker in pBluescript KSϩ. Transcripts were labeled with 50 Ci [␣-
32 P] UTP (25 Ci/mmol, ICN Biomedicals) and m 7 G5ЈpppG (cap) for 1 h at 37°C followed by 15 min of DNA digestion with DNase I. The transcribed RNA was purified on 6% Tris boric acid-EDTA buffer-urea polyacrylamide gels.
In vitro RNA decay assays
Transcripts were incubated with cytoplasmic extracts that were diluted to 1 g protein/l in a buffer containing 20 mM HEPES (pH 7.0), 20% glycerol, 100 mM KCl, 0.2 mM EDTA, 1 mM DTT, and 1 mM PMSF. The reaction mixture contained 10 g protein, 1 g synthetic poly A RNA, 2.6% poly vinyl alcohol, 1 mM ATP, 13 mM creatine phosphate, and RNA transcript (50,000 cpm). Aliquots were removed at different time-points and placed in 100 l stop solution containing 25 mM Tris, pH 7.6, 400 mM NaCl, 0.1% sodium dodecyl sulfate, and 10 g tRNA. For zero time (input) reaction, stop solution was added before the addition of RNA transcript. Samples were extracted with phenol-chloroform, ethanol-precipitated, and separated by electrophoresis using 5% polyacrylamide gels containing 7 M urea. Bands were visualized by autoradiography.
Data analysis
Band intensities were quantified by densitometric analyses using a personal densitometer (Molecular Dynamics, Sunnyvale, CA) and ImageQuant software. Statistical analysis was performed using the two-tailed, unpaired Student's t-test, and differences were determined to be statistically significant at a P value Ͻ0.05.
RESULTS
Dex enhances LPS induction of TF mRNA and activity in human monocytic THP-1 cells
We used human monocytic THP-1 cells to examine the mechanism by which Dex enhances LPS-induced TF expression in monocytes. We also analyzed TNF-␣ and MCP-1 expression as controls, as Dex inhibits LPS induction of these inflammatory mediators. LPS alone induced TF activity 8.8-fold (Fig. 1A) . Pretreatment of the cells with Dex (0.01, 0.1, and 1 M) strongly enhanced LPS-induced TF expression (Fig. 1A) . In contrast, Dex dose-dependently inhibited LPS-induced TNF-␣ expression (Fig. 1B) . Dex also reduced LPS-induced MCP-1 expression (Fig. 1C) . Dex alone weakly induced TF activity (Ͻtwofold) but had no effect on TNF-␣ and MCP-1 expression (Fig. 1) . Based on these results, we chose to use 1 M Dex for the study, as this concentration strongly enhanced TF expression and maximally inhibited TNF-␣ expression.
Next, we evaluated the effect of Dex on steady-state levels of TF mRNA to determine if Dex also enhances LPS-induced TF mRNA expression. LPS alone induced TF mRNA levels 13.5 Ϯ eightfold (meanϮSE, nϭ3), which was enhanced 4.2-fold by Dex (Fig. 2) . In contrast, Dex reduced LPS-induced TNF-␣ and MCP-1 mRNA expression. Dex alone weakly induced TF mRNA 2.5 Ϯ onefold but had no effect on TNF-␣ and MCP-1 mRNA levels (Fig. 2 ). These data demonstrate that Dex synergistically enhances LPS-induced TF activity and mRNA expression in monocytic cells but reduces LPS-induced TNF-␣ and MCP-1 mRNA expression.
Dex inhibits LPS induction of TF gene transcription
We analyzed the effect of Dex on LPS-induced TF gene transcription to determine if Dex enhances TF expression by increasing transcription. THP-1 cells were transfected with the reporter plasmids pTF-LUC, pTNF-␣-LUC, and pMCP-1-LUC and were stimulated with LPS in the presence and absence of Dex. LPS induced TF promoter activity 11.7-fold (Fig.  3A) . In contrast to Dex enhancement of LPS-induced TF mRNA and activity, Dex inhibited LPS-induced TF promoter activity by 58% (Fig. 3A) . Dex also inhibited LPS induction of the TNF-␣ and MCP-1 promoters (Fig. 3A) . Dex alone had no effect on the basal activities of any of these promoters. Further studies showed that Dex inhibited LPS induction of NF-Bdependent LUC expression from p(B) 4 LUC by 38% (not shown).
To exclude the possibility that a positively acting Dex response element was located outside the cloned TF promoter, we performed nuclear run-on experiments. LPS increased the rate of TF gene transcription 2.5-fold, which was reduced by 36% in the presence of Dex (Fig. 3B) . These results indicate that Dex enhancement of LPS-induced expression of TF is not a result of an enhancement of TF gene transcription. 
Dex increases the stability of TF mRNA
Our studies suggested that Dex enhancement of LPS-induced TF mRNA expression was mediated by a post-transcriptional mechanism. Therefore, we measured the stability of LPS-induced TF mRNA in the presence and absence of Dex using actinomycin D to inhibit TF gene transcription. We found that Dex increased the half-life of TF mRNA from 35 to 105 min (Fig. 4A) . Dex did not affect the stability of TNF-␣ mRNA but decreased the stability of MCP-1 mRNA (Fig. 4, B and C) . These data indicate that Dex increases the stability of TF mRNA in LPS-stimulated THP-1 cells.
Dex increases the stability of a TF transcript in in vitro decay assays
We performed in vitro decay assays to confirm the effect of Dex on the stability of TF mRNA and to localize the Dex-responsive region within the TF transcript. We focused our study on the last 297 nt of the TF 3Ј-UTR, as this region contains five AREs and is the most likely target of Dex-mediated stabilization (Fig.  5A) . A transcript containing 297 nt of the TF 3Ј-UTR and a poly A tail was incubated with cytoplasmic extracts from untreated THP-1 cells or cells treated with Dex alone, LPS alone, or Dex and LPS. The stability of the TF transcript was increased slightly when incubated with cytoplasmic extracts from cells treated with LPS or Dex alone compared with cytoplasmic extracts from unstimulated cells (Fig. 5B) . However, the TF transcript was most stable when incubated with cytoplasmic extracts from cells stimulated with Dex and LPS. A control transcript derived from pBluescript was stable for 60 min when incubated with the different cytoplasmic extracts (Fig. 5C) . The relative instability of the TF 3Ј-UTR transcript compared with the control transcript indicates that the TF 3Ј-UTR contains elements that mediate instability. These studies support our conclusion that Dex enhancement of LPSinduced TF mRNA expression in THP-1 cells is mediated by an increase in TF mRNA stability.
DISCUSSION
In this study, we showed that Dex dramatically enhanced the LPS induction of TF mRNA and activity in human monocytic cells. Analysis of the mechanism revealed that Dex inhibited LPS-induced TF gene transcription but enhanced TF mRNA stability. These results indicate that the post-transcriptional enhancement of TF mRNA stability by Dex in monocytic cells overcomes the inhibition of TF gene transcription, leading to a net enhancement of TF mRNA and protein expression.
We found that Dex inhibited LPS induction of TF gene expression in THP-1 cells in nuclear run-on experiments and in transient transfection experiments using a plasmid containing the human TF promoter. Dex also inhibited LPS induction of the TNF-␣ and MCP-1 promoters and NF-B-dependent gene expression. The TF, TNF-␣, and MCP-1 promoters are regulated by NF-B and AP-1 in monocytic and endothelial cells [4, 31, 32] . Thus, our studies are consistent with previous studies showing that Dex inhibits genes regulated by the transcription factors NF-B and AP-1 [12, 36] .
Analysis of TF mRNA stability in LPS-stimulated THP-1 cells in the presence and absence of Dex demonstrated that Dex enhancement of TF expression is mediated by a posttranscriptional mechanism. Measurement of TF mRNA stability showed that Dex increased the half-life of TF mRNA from 35 min to 105 min. The Dex-dependent stabilization of TF mRNA explains how Dex enhances LPS-induced TF mRNA and protein expression in THP-1 cells. This post-transcriptional mechanism would also explain why Dex alone weakly increases TF mRNA and activity without inducing TF gene transcription.
To further analyze the Dex-dependent stabilization of TF mRNA, we used in vitro decay assays. We focused on the last 297 nt of the TF 3Ј-UTR, as this region contains several AREs that include AUUUA pentamers, poly U tracks, and a UUAUUUAAU nanomer, all of which have been shown to regulate the stability of various mRNAs [21] [22] [23] [24] . Indeed, this TF 3Ј-UTR transcript was unstable compared with a control transcript, which is consistent with a previous study showing that the TF 3Ј-UTR conferred instability to a ␤-globin transcript [28] . We found that the stability of the TF transcript was increased when incubated with cytoplasmic extracts from cells stimulated with LPS alone or Dex alone compared with cytoplasmic extracts from unstimulated cells. LPS activation of the p38 mitogen-activated protein kinase (MAPK) pathway in THP-1 cells has been shown to increase the stability of a variety of ARE-containing mRNAs [37] . We previously demonstrated that LPS transiently stabilizes TF mRNA in THP-1 cells [3] . The current study extends this observation and shows that LPS-dependent stabilization is mediated by the last 297 nt of the TF transcript. At present, the mechanism by which LPS stabilizes TF mRNA has not been defined. It is important that the TF transcript was most stable when incubated with cytoplasmic extracts from cells stimulated with Dex and LPS. These results indicate that Dex enhancement of the stability of TF mRNA is mediated by a region(s) within the last 297 nt of the TF transcript.
Dex is used clinically in the treatment of various inflammatory diseases. Dex inhibits the expression of a variety of proinflammatory mediators at the transcriptional level by blocking NF-B and AP-1 activity. Dex enhancement of the LPS induction of TF in human monocytic cells is rather unusual. The only other examples of Dex enhancement of LPSinduced gene expression are the expression of soluble type II IL receptor expression by peripheral blood mononuclear cells and the expression of sialoadhesin by rat macrophages [38, 39] . In addition, treatment of mice with Dex enhanced neutrophil accumulation and macrophage-inflammatory protein-2 expression in the lungs of endotoxemic mice [40] . Further studies are required to determine if Dex enhancement of the LPS-induced expression of these genes is mediated via a common mechanism.
AREs in the 3Ј-UTRs of many inflammatory mediators are known to promote rapid mRNA degradation [21] [22] [23] [24] [25] . Other studies have shown that rates of mRNA decay can be modified in response to extracellular stimuli, such as LPS and IL-1␣. For example, we have shown that LPS stimulation of THP-1 cells transiently stabilizes TF mRNA [3] . A more recent study showed that LPS activation of the p38 MAPK pathway in monocytic THP-1 cells mediated the increased stability of a variety of ARE-containing mRNAs [37] . In addition, IL-1␣ enhancement of the stability of a variety of cytokine and chemokine mRNAs is dependent on the presence of ARE motifs in the 3Ј-UTRs [41] [42] [43] [44] . We speculate that Dex may induce the expression or function of a protein that stabilizes TF mRNA, such as Hu antigen receptor and ARE/poly(U)-binding/degradation factor-1 [45, 46] , or inhibit the expression or function of a protein that destabilizes TF mRNA, such as tristetrapolin [47] . The differential effects of Dex on the stability of TF, TNF-␣, and MCP-1 mRNAs in LPS-stimulated THP-1 cells may be a result of the different affinities of the stabilizing and destabilizing proteins for the AREs within these different mRNAs. Further studies are required to characterize the proteins that bind to the AREs and other sites in the TF 3Ј-UTR and to define the precise mechanism by which Dex enhances TF mRNA stability in human monocytic cells.
